Omeros Corp. Stock
Price
Target price
€9.34
€9.34
0.860%
0.08
0.860%
€30.88
29.05.26 / Frankfurt
WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omeros Corp. Stock
Omeros Corp. gained 0.860% compared to yesterday.
Omeros Corp. is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
Based on the current price of 9.34 € the target price of 30 € shows a potential of 221.2% for Omeros Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Omeros Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 0.860% | -8.431% | -24.372% | 233.333% | -30.815% | 73.284% | -25.040% |
| Heron Therapeutics Inc. | -2.030% | 0.745% | -27.059% | -54.244% | -33.214% | -37.479% | -93.168% |
| Evolus Inc | -1.250% | 5.855% | 24.175% | -30.415% | 1.505% | -30.415% | -37.843% |
| Rhythm Pharmaceuticals | -1.260% | 3.974% | 12.143% | 46.729% | -16.043% | 426.846% | 390.625% |
Comments
Omeros (OMER) had its "buy" rating reaffirmed by HC Wainwright. They now have a $40.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (OMER) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (OMER) was upgraded by Zacks Research from "hold" to "strong-buy".
Show more
Ratings data for OMER provided by MarketBeat
News
Omeros Q1 Earnings Call Highlights
Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA
Why Omeros Stock Skyrocketed Today
For the most part, the stock market tends to be sedate in the late holiday season. That sure wasn't the case on Wednesday with Omeros (NASDAQ: OMER), which saw a nearly 76% share price leap after
